GSK plc (LON:GSK) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of GSK plc (LON:GSK) have received an average rating of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is GBX 1,842.50 ($24.65).

A number of equities research analysts have issued reports on GSK shares. Citigroup reduced their price objective on shares of GSK from GBX 2,120 ($28.36) to GBX 1,900 ($25.41) and set a “buy” rating on the stock in a research note on Friday, July 5th. Berenberg Bank reissued a “buy” rating and issued a GBX 1,820 ($24.34) price objective on shares of GSK in a research note on Tuesday, September 10th. Jefferies Financial Group restated a “buy” rating and set a GBX 2,100 ($28.09) target price on shares of GSK in a research note on Thursday, June 27th. JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a research note on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,850 ($24.75) price objective on shares of GSK in a research report on Tuesday, September 3rd.

GSK Stock Down 0.1 %

Shares of GSK opened at GBX 1,459.50 ($19.52) on Friday. The company has a current ratio of 0.82, a quick ratio of 0.73 and a debt-to-equity ratio of 123.04. GSK has a 12 month low of GBX 1,371.40 ($18.34) and a 12 month high of GBX 1,823.50 ($24.39). The firm’s 50 day moving average is GBX 1,581.51 and its 200-day moving average is GBX 1,620.60. The stock has a market capitalization of £59.55 billion, a PE ratio of 1,291.59, a P/E/G ratio of 1.25 and a beta of 0.31.

GSK Dividend Announcement

The company also recently declared a dividend, which will be paid on Thursday, October 10th. Stockholders of record on Thursday, August 15th will be given a GBX 15 ($0.20) dividend. The ex-dividend date is Thursday, August 15th. This represents a dividend yield of 0.97%. GSK’s dividend payout ratio (DPR) is currently 5,309.73%.

Insider Transactions at GSK

In other GSK news, insider Elizabeth (Liz) McKee Anderson acquired 446 shares of the stock in a transaction dated Monday, September 23rd. The stock was purchased at an average cost of GBX 2,051 ($27.43) per share, with a total value of £9,147.46 ($12,235.77). 1.61% of the stock is currently owned by corporate insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.